LAMP1 and neoplasm: Importantly, when we analysed CD107a (LAMP-1), which is a sensitive marker of NK cell degranulation/cytotoxic activity, we observed significantly higher (P<0.001) levels of CD107+ NK cells in pEEVGmCSF-b7.1-treated groups when compared with untreated and pEEV control tumours.